Applied Therapeutics is a clinical-stage biopharmaceutical company developing therapies for diabetic complications. Its lead product candidate, AT-001, is an aldose reductase inhibitor (ARI) that is being developed for the treatment of diabetic cardiomyopathy, or DbCM, fatal fibrosis of the heart. The company is also developing AT-007, a central nervous system penetrant ARI, for the treatment of galactosemia.
|HQ||New York, US||Map|
Net income (FY, 2019)
EBIT (FY, 2019)
Market capitalization (2-Apr-2020)
Closing stock price (2-Apr-2020)
Applied Therapeutics has 19 Twitter Followers. The number of followers has increased 16.9% month over month and increased 99.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Applied Therapeutics founded?
Applied Therapeutics was founded in 2017.
Who are Applied Therapeutics key executives?
Applied Therapeutics's key executives are Shoshana Shendelman, Mark Vignola and Riccardo Perfetti.
How many employees does Applied Therapeutics have?
Applied Therapeutics has 4 employees.
Who are Applied Therapeutics competitors?
Competitors of Applied Therapeutics include Sensulin, glyscend and Pila Pharma.
Where is Applied Therapeutics headquarters?
Applied Therapeutics headquarters is located at 545 5th Ave #1400, New York.
Where are Applied Therapeutics offices?
Applied Therapeutics has an office in New York.
How many offices does Applied Therapeutics have?
Applied Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies